Nutritional Ingredients to Prevent, Recover from Heart Attack, Stroke (Escaping from Ischemia)

“Escaping from Ischemia” References

1. Spence JD. “Nutrition and stroke prevention.” Stroke. 2006 Sep;37(9):2430-5. Epub 2006 Jul 27.

2. Dalziel K, Segal L, de Lorgeril M. “A mediterranean diet is cost-effective in patients with previous myocardial infarction.” J Nutr. 2006 Jul;136(7):1879-85.

3. Trichopoulou A et al. “Modified Mediterranean diet and survival after myocardial infarction: the EPIC-Elderly study.” Eur J Epidemiol. 2007;22(12):871-81. Epub 2007 Oct 10.

4. Iestra J et al. “Lifestyle, Mediterranean diet and survival in European post-myocardial infarction patients.” Eur J Cardiovasc Prev Rehabil. 2006 Dec;13(6):894-900.

5. GISSI-Prevenzione Investigators. “Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial.” Eur J Clin Nutr. 2003 Apr;57(4):604-11.

6. Fung TT et al. “Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.” Arch Intern Med. 2008 Apr 14;168(7):713-20.

7. Folsom AR, Parker ED, Harnack LJ. “Degree of concordance with DASH diet guidelines and incidence of hypertension and fatal cardiovascular disease.” Am J Hypertens. 2007 Mar;20(3):225-32.

8. Psota TL, GebauerSK, Kris-Etherton P. “Dietary omega-3 fatty acid intake and cardiovascular risk.” Am J Cardiol. 2006 Aug 21;98(4A):3i-18i. Epub 2006 May 30.

9. He K et al. “Fish consumption and incidence of stroke: a meta-analysis of cohort studies.” Stroke. 2004 Jul;35(7):1538-42. Epub 2004 May 20.

10. Weber HS, Selimi D, Huber G. “Prevention of cardiovascular diseases and highly concentrated n-3 polyunsaturated fatty acids (PUFAs).” Herz. 2006 Dec;31 Suppl 3:24-30.

11. Yokoyama M et al. “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.” Lancet. 2007 Mar 31;369(9567):1090-8.

12. Burr ML. “Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel.” Proc Nutr Soc. 2007 Feb;66(1):9-15.

13. Den Ruijter HM et al. “Pro- and antiarrhythmic properties of a diet rich in fish oil.” Cardiovasc Res. 2007 Jan 15;73(2):316-25. Epub 2006 Jun 16.

14. Schwedhelm E et al. “Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.” Br J Clin Pharmacol. 2008 Jan;65(1):51-9. Epub 2007 Jul 27.

15. Loscalzo J. “L-arginine and atherothrombosis.” J Nutr. 2004;134:2798S-2800S.

16. Gornik HL, Creager MA. “Arginine and endothelial and vascular health.” J Nutr. 2004;134:2880S-2887S.

17. Du L et al. “Synergistic myoprotection of L-arginine and adenosine in a canine model of global myocardial ischaemic reperfusion injury.” Chin Med J (Engl). 2007 Nov 20;120(22):1975-81.

18. Soós P et al. “Myocardial protection after systemic application of L-arginine during reperfusion.” J Cardiovasc Pharmacol. 2004 Jun;43(6):782-8.

19. Bednarz B et al. “Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial.” Kardiol Pol. 2005 May;62(5):421-7.

20. Kiziltepe U et al. “Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts.” Int J Cardiol. 2004 Oct;97(1):93-100.

21. Ueno T et al. “Taurine at early reperfusion significantly reduces myocardial damage and preserves cardiac function in the isolated rat heart.” Resuscitation. 2007 May;73(2):287-95. Epub 2007 Mar 13.

22. Akin M et al. “Comparison of the effects of sodium nitroprusside and L-carnitine in experimental ischemia-reperfusion injury in rats.” Transplant Proc. 2007 Dec;39(10):2997-3001.

23. Picconi B et al. “Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine.” Neuropharmacology. 2006 Jun;50(8):917-23. Epub 2006 Feb 24.

24. Lesnefsky EJ et al. “Reversal of mitochondrial defects before ischemia protects the aged heart.” FASEB J. 2006 Jul;20(9):1543-5. Epub 2006 Jun 22.

25. Briet F et al. “Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats.” Nutr Metab Cardiovasc Dis. 2008 Mar 21. [Epub ahead of print]

26. Kalenikova EI et al. “Chronic administration of coenzyme Q10 limits postinfarct myocardial remodeling in rats.” Biochemistry (Mosc). 2007 Mar;72(3):332-8.

27. Crestanello JA et al. “Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion.” J Surg Res. 2002 Feb;102(2):221-8.

28. Young AJ et al. “Coenzyme Q10: a review of its promise as a neuroprotectant.” CNS Spectr. 2007 Jan;12(1):62-8.

29. Das S et al. “Cardioprotection with palm oil tocotrienols: comparison of different isomers.” Am J Physiol Heart Circ Physiol. 2008;294:H970-H978. DOI:10.1152/ajpheart.01200.2007.

30. Sen CK et al. “Tocotrienol potently inhibits glutamate-induced pp60(c-src) kinase activation and death of HT4 neuronal cells—molecular basis of vitamin E action.” J Biol Chem. 2000;275(17):13049-55.

31. Sen CK et al. “Vitamin E sensitive genes in the developing rat fetal brain: a high density oligonucleotide microarray analysis.” FEBS Letter. 2002;530:17-23.

32. Sen CK et al. “Neuroprotective properties of the natural vitamin E alpha-tocotrienol.” Stroke. 2005;36:e144-e152.

33. Qin F et al. “Vitamins C and E attenuate apoptosis, beta-adrenergic receptor desensitization, and sarcoplasmic reticular Ca2+ ATPase downregulation after myocardial infarction.” Free Radic Biol Med. 2006 May 15;40(10):1827-42. Epub 2006 Feb 8.

34. Jaxa-Chamiec T et al. “Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial.” Kardiol Pol. 2005 Apr;62(4):344-50.

35. Ullegaddi R, Powers HJ, Gariballa SE. “Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial.” JPEN J Parenter Enteral Nutr. 2006 Mar-Apr;30(2):108-14.

36. Hussein G et al. “Antihypertensive and neuroprotective effects of astaxanthin in experimental animals.” Biol Pharm Bull. 2005;28(1):47-52.

37. Hussein G et al. “Astaxanthin, a carotenoid with potential in human health and nutrition.” J Nat Prod. 2006;69:443-49.

38. Gross GJ, Lockwood SF. “Acute and chronic administration of disodium disuccinate astaxanthin (Cardax) produces marked cardioprotection in dog hearts.” Mol Cell Biochem. 2005 Apr;272(1-2):221-7.

39. Gross GJ, Lockwood SF. “Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax™).” Life Sci. 2004;75:215-24.

40. Mursu J et al. “Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study.” Br J Nutr. 2008 Apr 1:1-6. [Epub ahead of print]

41. Tavani A et al. “Intake of specific flavonoids and risk of acute myocardial infarction in Italy.” Public Health Nutr. 2006 May;9(3):369-74.

42. Kokubo Y et al. “Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I.” Circulation. 2007 Nov 27;116(22):2553-62. Epub 2007 Nov 19.

43. Booyse FM et al. “Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk.” Ann Epidemiol. 2007 May;17(5 Suppl):S24-31.

44. Edirisinghe I, Burton-Freeman B, Kappagoda CT. “Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract.” Clin Sci. 2008;114:331-7. DOI:10.1042/CS20070264

45. Pataki T et al. “Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts.” Am J Clin Nutr. 2002 May;75(5):894-9.

46. Hwang IK et al. “Neuroprotective effects of grape seed extract on neuronal injury by inhibiting DNA damage in the gerbil hippocampus after transient forebrain ischemia.” Life Sci. 2004 Sep 3;75(16):1989-2001.

47. Feng Y et al. “Grape seed extract given three hours after injury suppresses lipid peroxidation and reduces hypoxic-ischemic brain injury in neonatal rats.” Pediatr Res. 2007 Mar;61(3):295-300.

48. Aldini G et al. “Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection.” Life Sci. 2003;73:2883-98.

49. Berti F et al. “Procyanidins from Vitis vinifera seeds display cardioprotection in an experimental model of ischemia-reperfusion damage.” Drugs Exp Clin Res. 2003;29(5-6):207-16.

50. Sutherland BA, Rahman RM, AppletonI. “Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration.” J Nutr Biochem. 2006 May;17(5):291-306. Epub 2005 Nov 8.

51. Suzuki M et al. “Protective effects of green tea catechins on cerebral ischemic damage.” Med Sci Monit. 2004 Jun;10(6):BR166-74. Epub 2004 Jun 1.

52. Devika PT, Stanely Mainzen Prince P. “Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: A histopathological study.” Biomed Pharmacother. 2007 Nov 20. [Epub ahead of print]

53. Townsend PA et al. “Epigallocatechin-3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis.” FASEB J. ePub Aug. 19, 2004. DOI:10.1096/fj.04-1716fje.

54. Wang Y et al. “Dietary supplementation with blueberries, spinach, or spirulina reduces ischemic brain damage.” Exp Neurol. 2005 May;193(1):75-84.

55. Sweeney MI et al. “Feeding rats diets enriched in lowbush blueberries for six weeks decreases ischemia-induced brain damage.” Nutr Neurosci. 2002 Dec;5(6):427-31.

56. Khan M et al. “C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling.” Am J Physiol Heart Circ Physiol. 2006 May;290(5):H2136-45. Epub 2005 Dec 22.

57. Paganelli RA, Benetoli A, Milani H. “Sustained neuroprotection and facilitation of behavioral recovery by the Ginkgo biloba extract, EGb 761, after transient forebrain ischemia in rats.” Behav Brain Res. 2006 Nov 1;174(1):70-7. Epub 2006 Aug 24.

58. Uríková A et al. “Impact of Ginkgo Biloba Extract EGb 761 on ischemia/reperfusion - induced oxidative stress products formation in rat forebrain.” Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1343-53. Epub 2006 Apr 14.

59. Schneider R et al. “Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb 761: I. cardiomyocytes.” Histol Histopathol. 2008 Jul;23(7):807-17.

60. Carini M et al. “Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat.” Planta Med. 2001;67:236-30.

61. Weikert C et al. “B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort.” Stroke. 2007 Nov;38(11):2912-8. Epub 2007 Sep 20.

62. Atanassova PA et al. “Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients.” Arq Neuropsiquiatr. 2007 Mar;65(1):24-31.

63. Yang LK et al. “Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients.” J Am Coll Nutr. 2007 Jun;26(3):272-8.

64. Drogan D et al. “Dietary intake of folate equivalents and risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam study.” Public Health Nutr. 2006 Jun;9(4):465-71.

65. Larsson SC et al. “Folate, vitamin B6, vitamin B12, and methionine intakes and risk of stroke subtypes in male smokers.” Am J Epidemiol. 2008 Apr 15;167(8):954-61. Epub 2008 Feb 12.

66. Pezzini A, Del Zotto E, Padovani A. “Homocysteine and cerebral ischemia: pathogenic and therapeutical implications.” Curr Med Chem. 2007;14(3):249-63.

67. Albert CM et al. “Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.” JAMA. 2008 May 7;299(17):2027-36.

68. Moens AL et al. “Effect of folic acid on endothelial function following acute myocardial infarction.” Am J Cardiol. 2007 Feb 15;99(4):476-81. Epub 2006 Dec 28.

69. Perkowski D, Wagner S, St.Cyr J. “D-ribose and “off” pump coronary artery bypass revascularization aids cardiac indices following acute myocardial infarction.” J Heart Dis. 2007;5(Supp 1):92.

70. Befera N et al. “Ribose treatment helps preserve function of the remote myocardium after myocardial infarction.” J Surg Res. 2007;137(2):156.

71. Wallen WJ, Belanger MP, Wittnich C. “Preischemic administration of ribose to delay the onset of irreversible ischemic injury and improve function: studies in normal and hypertrophied hearts.” Can J Physiol Pharmacol. 2003 Jan;81(1):40-7.

72. Kim JM et al. “Dietary S-allyl-L-cysteine reduces mortality with decreased incidence of stroke and behavioral changes in stroke-prone spontaneously hypertensive rats.” Biosci Biotechnol Biochem. 2006;70(8):1969-71.

73. Weiss N et al. “Aged garlic extract improves homocysteine-induced endothelial dysfunction in macro- and microcirculation.” J Nutr. 2006;136(3S):750S-54S.

74. Williams MJ et al. “Aged garlic extract improves endothelial function in men with coronary artery disease.” Phytother Res. 2005;19(4):314-9.

75. Budoff MJ et al. “Aged Garlic Extract improves vascular function in asymptomatic individuals with subclinical atherosclerosis.” Experimental Biology. San Diego. April 5-9, 2008. Abst # 442.5.

76. Budoff MJ et al. “Garlic therapy retards coronary artery calcification.” Experimental Biology. San Diego. April 5-9, 2008. Abst # 1094.4.